These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27368714)

  • 1. Febrile ulceronecrotic Mucha-Habermann disease in an 8-year-old boy responding to methotrexate.
    Alratrout J; Alshammasi F; Ansari N
    Int J Dermatol; 2016 Nov; 55(11):1205-1209. PubMed ID: 27368714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.
    Suárez J; López B; Villalba R; Perera A
    Dermatology; 1996; 192(3):277-9. PubMed ID: 8726649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Febrile ulceronecrotic Mucha-Habermann disease].
    Dupin A; Bosset D; Atger L; Chevallier B; Saiag P; Benoist G
    Arch Pediatr; 2016 Jan; 23(1):82-5. PubMed ID: 26552626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febrile ulceronecrotic Mucha-Habermann disease with extensive skin necrosis in intertriginous areas.
    Yang CC; Lee JY; Chen W
    Eur J Dermatol; 2003; 13(5):493-6. PubMed ID: 14693498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alpha.
    Tsianakas A; Hoeger PH
    Br J Dermatol; 2005 Apr; 152(4):794-9. PubMed ID: 15840118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) associated with parvovirus infection.
    Nanda A; Alshalfan F; Al-Otaibi M; Al-Sabah H; Rajy JM
    Am J Dermatopathol; 2013 Jun; 35(4):503-6. PubMed ID: 23612031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile ulceronecrotic Mucha-Habermann disease in a 34-month-old boy: a case report and review of the literature.
    Perrin BS; Yan AC; Treat JR
    Pediatr Dermatol; 2012; 29(1):53-8. PubMed ID: 21906156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile ulceronecrotic Mucha-Habermann disease: proposed diagnostic criteria and therapeutic evaluation.
    Nofal A; Assaf M; Alakad R; Amer H; Nofal E; Yosef A
    Int J Dermatol; 2016 Jul; 55(7):729-38. PubMed ID: 26695875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febrile Ulceronecrotic Mucha-Habermann Disease: A Case Report and Review of Literature in the Paediatric Population.
    Liu J; Zhong J; Wang Q; Cai Y; Chen J
    Acta Derm Venereol; 2023 Apr; 103():adv4806. PubMed ID: 37073962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Febrile ulceronecrotic Mucha-Habermann disease].
    Arellano Lorca J; Yáñez Silva I; Soto Vilches F; Luna Heine A; Corredoira Salum Y
    Rev Med Chil; 2016 Sep; 144(9):1214-1217. PubMed ID: 28060985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febrile ulceronecrotic Mucha-Habermann's disease with pulmonary involvement.
    Zhang LX; Liang Y; Liu Y; Ma L
    Pediatr Dermatol; 2010; 27(3):290-3. PubMed ID: 20609148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.
    Sotiriou E; Patsatsi A; Tsorova C; Lazaridou E; Sotiriadis D
    Acta Derm Venereol; 2008; 88(4):350-5. PubMed ID: 18709304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Febrile ulceronecrotic Mucha-Habermann disease: a case with systemic symptoms managed with subcutaneous methotrexate.
    Lin CY; Cook J; Purvis D
    Australas J Dermatol; 2012 Nov; 53(4):e83-6. PubMed ID: 23157793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of febrile ulceronecrotic Mucha-Habermann disease responsive to systemic corticosteroids.
    Rai E; Kamzan A; Boozalis E; Hogeling M; Fong K
    Pediatr Dermatol; 2023; 40(3):573-575. PubMed ID: 36573550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid recovery in a child with febrile ulceronecrotic Mucha-Habermann disease following intravenous immunoglobulin administration.
    Somasundaram A; Gupta A; Sathishkumar D; Mathew L; George A; Thomas M
    Pediatr Dermatol; 2024; 41(3):518-522. PubMed ID: 38234081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febrile ulceronecrotic Mucha-Habermann disease with central nervous system vasculitis.
    Rosman IS; Liang LC; Patil S; Bayliss SJ; White AJ
    Pediatr Dermatol; 2013; 30(1):90-3. PubMed ID: 22276640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity?
    Cozzio A; Hafner J; Kempf W; Häffner A; Palmedo G; Michaelis S; Gilliet M; Zimmermann D; Burg G
    J Am Acad Dermatol; 2004 Dec; 51(6):1014-7. PubMed ID: 15583604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Diagnostically Challenging Case of Febrile Ulceronecrotic Mucha-Habermann Disease in an Adult Female Successfully Treated with Methotrexate and Cyclosporine.
    Ngo T; Hossain C; Cohen J; McLellan B; Blasiak R; Balagula E
    Case Rep Dermatol; 2021; 13(1):12-17. PubMed ID: 33613228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease.
    Marenco F; Fava P; Fierro MT; Quaglino P; Bernengo MG
    Dermatol Ther; 2010; 23(4):419-22. PubMed ID: 20666830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of febrile ulceronecrotic Mucha-Habermann disease requiring debridement of necrotic skin and epidermal autograft.
    Yanaba K; Ito M; Sasaki H; Inoue M; Nobeyama Y; Yonemoto H; Ishiji T; Tanaka H; Kamide R; Niimura M
    Br J Dermatol; 2002 Dec; 147(6):1249-53. PubMed ID: 12452879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.